Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures
CONCLUSIONS: We cannot draw conclusions from the current evidence due to lack of data. Most published studies included in our analyses assessed the use of tranexamic acid (compared to placebo, or using different routes of administration). We identified 27 prospectively registered ongoing RCTs (total target recruitment of 4177 participants by end of 2023). The ongoing trials create six new comparisons: tranexamic acid (tablet + injection) versus placebo; intravenous tranexamic acid versus oral tranexamic acid; topical tranexamic acid versus oral tranexamic acid; different intravenous tranexamic acid dosing regimes; topical tranexamic acid versus topical fibrin glue; and fibrinogen (injection) versus placebo.PMID:37272509 | DOI:10.1002/14651858.CD013499.pub2
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Victoria N Gibbs Rita Champaneria Louise J Geneen Parag Raval Carolyn Dor ée Susan J Brunskill Alex Novak Antony Jr Palmer Lise J Estcourt Source Type: research
More News: Accidents | Anemia | Bed Wetting | Bleeding | Blood Transusion | Clinical Trials | Databases & Libraries | Drugs & Pharmacology | Enuresis | General Medicine | Heart Attack | Orthopaedics | Pulmonary Thromboembolism | Stroke | Study | Thrombosis